Literature DB >> 17007942

Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus.

J K L Eng1, W J Blackhall, M Y Osei-Atweneboana, C Bourguinat, D Galazzo, R N Beech, T R Unnasch, K Awadzi, G W Lubega, R K Prichard.   

Abstract

Ivermectin resistance is common in trichostrongylid nematodes of livestock, such as Haemonchus contortus. This anthelmintic is the only drug approved for mass administration to control onchocerciasis caused by the nematode parasite, Onchocerca volvulus. In parts of West Africa up to 18 rounds of ivermectin treatment have been administered to communities and there are reports of poor parasitological responses to treatment. Understanding ivermectin resistance and ivermectin selection is an important step to reduce selection pressure for resistance, and to develop molecular markers which can be used to monitor the development of resistance and its spread. Here we report evidence that ivermectin selection changes the frequency of beta-tubulin alleles in both the sheep parasite, H. contortus, and the human parasite, O. volvulus. In O. volvulus we have been able to look at the frequency of beta-tubulin alleles in O. volvulus obtained before any ivermectin was used in humans in Africa, and following its widespread use. In H. contortus, we have been able to look at the frequency of beta-tubulin alleles in a strain which has not seen any anthelmintic selection and in an ivermectin selected strain derived from the unselected strain. We have found ivermectin selects on beta-tubulin in both of these nematode species. In the case of O. volvulus, we had previously reported that ivermectin selects for specific single nucleotide polymorphisms in the O. volvulus beta-tubulin gene. This polymorphism results in three amino acid changes in the H3 helix of beta-tubulin, as well as deletions in an associated intron. We report a simple PCR assay to detect the amplicon length polymorphism, resulting from these intronic deletions, which can be used to monitor the frequency of the beta-tubulin allele selected for by ivermectin in O. volvulus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17007942     DOI: 10.1016/j.molbiopara.2006.08.007

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  24 in total

1.  Molecular and biological diagnostic tests for monitoring benzimidazole resistance in human soil-transmitted helminths.

Authors:  Aïssatou Diawara; Jan M Schwenkenbecher; Ray M Kaplan; Roger K Prichard
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

2.  The Wolbachia endosymbiont as an anti-filarial nematode target.

Authors:  Barton E Slatko; Mark J Taylor; Jeremy M Foster
Journal:  Symbiosis       Date:  2010-06-05       Impact factor: 2.268

3.  The putative cyclooctadepsipeptide receptor depsiphilin of the canine hookworm Ancylostoma caninum.

Authors:  Nina Krüger; Achim Harder; Georg von Samson-Himmelstjerna
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

4.  Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus.

Authors:  Achim Hoerauf; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Peter Konadu; Sabine Mand; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-04-18       Impact factor: 2.289

Review 5.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

Authors:  Anne Lespine; Cécile Ménez; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-07       Impact factor: 4.077

6.  Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.

Authors:  Mike Y Osei-Atweneboana; Daniel A Boakye; Kwablah Awadzi; John O Gyapong; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-02-12       Impact factor: 4.077

Review 7.  A research agenda for helminth diseases of humans: intervention for control and elimination.

Authors:  Roger K Prichard; María-Gloria Basáñez; Boakye A Boatin; James S McCarthy; Héctor H García; Guo-Jing Yang; Banchob Sripa; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

8.  Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.

Authors:  Mike Y Osei-Atweneboana; Kwablah Awadzi; Simon K Attah; Daniel A Boakye; John O Gyapong; Roger K Prichard
Journal:  PLoS Negl Trop Dis       Date:  2011-03-29

9.  Moxidectin: a review of chemistry, pharmacokinetics and use in horses.

Authors:  Rami Cobb; Albert Boeckh
Journal:  Parasit Vectors       Date:  2009-09-25       Impact factor: 3.876

10.  Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Authors:  Sébastien D S Pion; Hugues C Nana-Djeunga; Joseph Kamgno; Nicholas Tendongfor; Samuel Wanji; Flobert Njiokou; Roger K Prichard; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.